How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example

Clin Pharmacol Ther. 2023 Feb;113(2):310-320
Meyer C, Dierick I, Gauderat G, Langenhorst J, Sarr C, Leroux E, Chenel M, Fouliard S, Passier P.
CardiovascularJournalMIDDPharmacometricsProgram strategies and efficienciesRegulatory interactions

Pharmetheus Affiliates

Portrait-of-Jurgen-Langenhorst-Pharmetheus
Senior Director, MIDD Consultant

Jurgen Langenhorst

See bio
Portrait-of-Celine-Sarr_Pharmetheus
Principal Director, MIDD Consultant

Céline Sarr

See bio
Portrait-of-Marylore-Chenel_Pharmetheus
Chief Research Officer

Marylore Chenel

See bio